Elekta ABEKTAF 77 Market Cap is $1,922 Mil as of Jun. 30, 2026. GuruFocus rates EKTAF with a GF Score™ of 77/100 and a GF Value™ of $6.07 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Elekta AB ranks better than 87.77% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Elekta AB's share price for the quarter that ended in Apr. 2026 was $6.2. Elekta AB's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 382 Mil. Therefore, Elekta AB's market cap for the quarter that ended in Apr. 2026 was $2,369 Mil.
Elekta AB's quarterly market cap
increased
from Oct. 2025 ($1,930 Mil) to Jan. 2026 ($2,476 Mil) but then
declined
from Jan. 2026 ($2,476 Mil) to Apr. 2026 ($2,369 Mil).
Elekta AB's annual market cap
declined
from Apr. 2024 ($2,889 Mil) to Apr. 2025 ($1,910 Mil) but then
increased
from Apr. 2025 ($1,910 Mil) to Apr. 2026 ($2,369 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Elekta AB's Enterprise Value for Today is $2,352 Mil.
Elekta AB (OTCPK:EKTAF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Elekta AB Market Cap Related Terms
Elekta AB Market Cap Historical Data
* Premium members only.
The historical data trend for Elekta AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Elekta AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Elekta AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Elekta AB's Market Cap for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB (EKTAF) has a Market Cap of $1,922 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Elekta AB and its competitors. According to the industry distribution chart, Elekta AB ranks #106 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 12.2%.
Is Elekta AB's Market Cap too high?
Elekta AB's current Market Cap is $1,922 Mil. The Medical Devices & Instruments industry median Market Cap is 120.18. Elekta AB's value of $1,922 Mil is 1499.3% above this industry median. Based on the distribution chart, Elekta AB ranks #106 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Elekta AB has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #106 out of 867 companies for Market Cap. This places Elekta AB in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.18. Elekta AB's value of $1,922 Mil is 1499.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elekta AB's current Market Cap of $1,922 Mil is 1499.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current Market Cap is $1,922 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.07, compared to a current price of $5.04 — trading 17% below its estimated fair value. The current Market Cap is $1,922 Mil and 1499.3% above the Medical Devices & Instruments industry median of 120.18. Elekta AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Elekta AB (EKTAF), the current Market Cap is $1,922 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (EKTAF) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of $5.04 is trading 17% below its estimated GF Value™ of $6.07.
GuruFocus considers Elekta AB to be Modestly Undervalued.
Key valuation signals for EKTAF:
Market Cap: $1,922 Mil
GF Value™: $6.07 vs. price of $5.04 (17% below fair value)
Industry Position: 1499.3% above the Medical Devices & Instruments median (#106 of 867)
No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
77GF Score
Get the complete analysis for EKTAF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKTAF has been successfully added to your 
